About us
The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Upcoming seminars
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (sixkille@ohsu.edu) if you would like a link to the live stream.
Recent publications
OHSU, May 22, 2020
Coronavirus survivors could be protected against future illness, study suggests
Science, May 20, 2020
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Methods Mol Biol, 2020
Analysis of Serum Anti-Zika Virus Antibodies by Focus Reduction Neutralization Test.
Methods Mol Biol, 2020
Isolation and Detection of Zika Virus-Infected Rhesus Macaques Lymph Node Cells and Splenocytes.
J Immunol, May 6, 2020
Systematic Profiling of Full-Length Ig and TCR Repertoire Diversity in Rhesus Macaque through Long Read Transcriptome Sequencing.
Nat Med, April 26, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.
Donate to VGTI
Your gifts help provide vital resources to conduct innovative research and more.
COVID-19 Efforts - Building a COVID Testing Lab